• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / NEOADJUVANT THERAPY FOR RECTAL CANCER: IS SURGERY THE BEST CONSECUTIVE OPTION FOR EVERYBODY?

NEOADJUVANT THERAPY FOR RECTAL CANCER: IS SURGERY THE BEST CONSECUTIVE OPTION FOR EVERYBODY?

Angela Maurizi, MD1, Susanna Mazzocato, MD2, Francesco Falsetti, MD1, Giorgio Degano, MD1, Mario Masella, MD1, Roberto Campagnacci, MD, PhD1. 1General Surgery, ASUR Regione Marche, “Carlo Urbani” Hospital, Jesi, Italy, 2Department of General Surgery, Università Politecnica delle Marche, 60126 Ancona, Italy

INTRODUCTION: Currently, neoadjuvant chemo-radiotherapy (nCRT) followed by low anterior resection or abdominoperineal resection are the standard treatments for locally advanced rectal cancer. nCRT can improve resecability, achieve better sphincter preservation and reduce local recurrence. Although total mesorectal excision is the standard treatment for advanced rectal cancer, recent trends in minimally invasive treatments led to an increase in local excision or “watch and wait” in patients with an excellent response to nCRT. The purpose of this study, part of an ongoing research, is critically evaluating the feasibility of “non-operative treatment” for rectal cancer in a district hospital.

METHODS AND PROCEDURES: A total of 29 patients with rectal cancer, who where treated with nCRT from January to August 2017 at “Carlo Urbani” district Hospital in Jesi (Italy), were retrospectively reviewed. All patients had histologically-confirmed primary adenocarcinoma of the rectum located within 12 cm from the anal verge. The involved patients completed nCRT and had no recurrence disease, distant metastasis, synchronous malignancies. They were classified according to the Mandard’s Tumor Regression Grade (TRG) into two clusters: group A (TRG 1-3) and B (TRG 4-5).  

RESULTS: The average age of people is 67.2 and 17 were male. Five patients underwent abdominoperineal resection and 76% fell within group A. Six patients had lymph nodes involved. Four patients suffered relevant complications, such as wound complication, anastomotic leak, operative reintervention and death. Univariate analysis showed that the main predictors of tumor regression were the absence of lymph-nodes involvement from initial imaging (p<0.05), normal initial carcinoembryonic antigen level (p<0.05) and tumor downstaging in imaging (p<0.05). In addition, most relevant complications occurred to elderly patients although they observed a good clinical response. Besides, 13% of patients were found to be complete pathologic responders upon examination of the surgical specimen.

CONCLUSIONS: The oncologic feasibility of non-operative management for the patients with complete clinical response after nCRT has been growing, but some studies have suggested lack of oncologic safety in these patients. The patients with a complete clinical response expect good survival, but they may still harbor residual disease. No consensus on “watch and wait” policy in the field of rectal cancer was obtained, yet. Our data did not entirely support this policy although it might be the best strategy, based on the predictors of tumor regression, to avoid the complications associated with surgery in elderly patients with significant medical comorbidities and fear of a permanent stoma.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 86677

Program Number: P266

Presentation Session: iPoster Session (Non CME)

Presentation Type: Poster

41

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals